Digital health spectators have long eyed therapeutic virtual reality’s progression from an interesting research concept to an evidence-backed treatment for pain, phobias and other conditions. But with COVID-19 throwing a wrench into healthcare’s status quo, will the virtual technology be seen as a key resource, or as a novelty to be sidelined until things can return to normal?
In this episode, VR researcher and advocate Dr. Robert Louis, endowed chair and program director at the Pickup Family Neurosciences Institute, and director of XR Development at Hoag Memorial Hospital, joins host Jonah Comstock and Associate Editor Dave Muoio to discuss how his hospital’s VR initiatives have been affected by the pandemic.
(Editor’s note: Louis serves as an advisor for Cleanbox Technology, mentioned in this episode)
More related to this episode:
In-depth: Despite some hiccups, COVID-19 is VR’s time to shine
XRHealth raises $7M to expand its VR telehealth platform
Oxford VR puts patients with social anxiety into virtual scenarios with new program
Reimagining Brain Surgery (YouTube demo)